Veterinary drugs no longer need testing for carcinogenicity in rodent bioassays

Regulatory Toxicology and Pharmacology

Volumn 28, Issue 2, 1998, Pages 115-123

  Galer, D M ^a   Monro, A M ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DERMATOLOGICAL AGENT; IMMUNOSUPPRESSIVE AGENT; STEROID; VETERINARY DRUG;

ARTICLE; BIOASSAY; CANCER RISK; CARCINOGEN TESTING; DRUG CARCINOGENICITY; GENOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALIA; RODENTIA;

EID: 0032451385     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1998.1248     Document Type: Article

References (53)

1. Alison R. H., Capen C. C., Prentice D. E. Neoplastic lesions of questionable significance to humans. Toxicol. Pathol. 22:1994;179-186.
2. Allen B. C., Crump K. S., Shipp A. M. Correlation between carcinogenic potency of chemicals in animals and humans. Risk Anal. 8:1988;531-544.
3. Altman P. L., Dittmer D. S. Growth. 1962;FASEB, Washington.
4. Ames B. N., Gold L. S. Chemical carcinogenesis: Too many rodent carcinogens. Proc. Nat. Acad. Sci. USA. 87:1990;7772-7776.
5. Ames B. N., Gold L. S., Willett W. C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA. 92:1995;5258-5265.
6. Ashby J., Tennant R. W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257:1991;229-306.
7. Ashby J., Tennant R. W. Prediction of rodent carcinogenicity for 44 chemicals: Results. Mutagenesis. 9:1994;7-15.
8. Borzelleca J. F. A proposed model for safety assessment of macronutrient substitutes. Regul. Toxicol. Pharmacol. 23:1996;S15-S18.
9. Brown L. P., Ashby J. Correlations between bioassay dose-level, mutagenicity to salmonella, chemical structure and sites of carcinogenesis among 226 chemicals evaluated for carcinogenicity by the U.S. NTP. Mutat. Res. 244:1990;67-76.
10. Butterworth B. E. Consideration of both genotoxic and non-genotoxic mechanisms in predicting carcinogenic potential. Mutat. Res. 239:1990;117-132.
11. Codex Committee, 1996, Residues of Veterinary Drugs and Foods: Ad Hoc Working Group of Analysis and Sampling, 127, 134.
12. Cohen S. M. Human relevance of animal carcinogenicity studies. Regul. Toxicol. Pharmacol. 21:1995;75-80.
13. Cohen S. M., Ellwein L. B. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51:1990;6493-6505.
14. Commission of the European Communities (CEC), 1991, The Rules Governing Medicinal Products in the European Community, VI, Establishment by the European Community of Maximum Residue Limits (MRLs) for Residues of Veterinary Medicinal Products.
15. Crouch E., Wilson R. Interspecies comparison of carcinogenic potency. J. Toxicol. Environ. Health. 5:1979;1095-1118.
16. Davies T. S., Monro A. The rodent carcinogenicity bioassay produces a similar frequency of tumor increases and decreases: Implications for risk assessment. Regul. Toxicol. Pharmacol. 20:1994;281-301.
17. Davies T. S., Monro A. Marketed human pharmaceuticals reported to be tumorigenic in rodents. J. Am. Coll. Toxicol. 14:1995;90-107.
18. Doll R., Peto R. The causes of cancer. J. Natl. Cancer Inst. 66:1981;1191-1308.
19. Center for Veterinary Medicines: General Principles for Evaluating the Safety of Compounds Used in Food-Producing Animals. 1994;FDA, Washington.
20. Fed. Reg. 60:1995;36582-36596.
21. Flamm W. G., Kotsonis F. N., Hjelle J. J. Threshold of regulation: a unifying concept in food safety assessment. Nutritional Toxicology. 1994;Raven Press, New York. p. 223-233.
22. Gold L. S., Bernstein L., Magaw R. Interspecies extrapolation in carcinogenesis: Prediction between rats and mice. Environ. Health Perspect. 81:1989;211-219.
23. Gold L. S., Slone T. H., Ames B. N. Prioritization of possible carcinogenic hazards in food. Tennant D. Food Chemical Risk Analysis. 1996;Chapman and Hall, London.
24. Gold L. S., Slone T. H., Stern B. R., Manley N. B., Ames B. N. Rodent carcinogens: Setting priorities. Science. 258:1992;261-265.
25. Gold L. S., Slone T. H., Manley N. B., Ames B. N. Heterocyclic amines formed by cooking food: Comparison of bioassay results with other chemicals in the carcinogenic potency data base. Cancer Lett. 83:1994;21-29.
26. Goodman J. I. A rational approach to risk assessment requires the use of biological information: an analysis of the National Toxicology Program (NTP), final report of the advisory review by the NTP Board of Scientific Counsellors. Regul. Toxicol. Pharmacol. 19:1994;51-59.
27. Gori G. B., Flamm W. G. How sick a patient. Regul. Toxicol. Pharmacol. 14:1991;215-222.
28. Grasso P., Sharratt M., Cohen A. J. Role of persistent, non-genotoxic tissue damage on rodent cancer and relevance to humans. Annu. Rev. Pharmacol. Toxicol. 31:1991;253-287.
29. Henderson B. E., Ross R. K., Pike M. C. Toward the primary prevention of cancer. Science. 254:1991;1131-1138.
30. Huff J., Haseman J. K., Rall D. Scientific concepts, value and significance of chemical carcinogenesis studies. Ann. Rev. Pharmacol. Toxicol. 31:1991;621-652.
31. ICH, 1998, Testing for carcinogenicity of pharmaceuticals, Proceedings of 4th International Conference on Harmonisation, P. D'ArcyD. Harron, 949, 958, Queen's Univ. Press, Belfast.
32. IPCS/JECFA, 1987, Environmental Health Criteria 70. Principles for the Safety Assessment of Food Additives and Contamination in Food.
33. Kroes R., Munro I. C., Poulsen E. Workshop on the scientific evaluation of the safety factor for the acceptable daily intake (ADI): Editorial summary. Food Add. Contam. 10:1993;269-273.
34. Linkov I., Wilson R., Gray G. M. Anticarcinogenic responses in rodent cancer bioassays are not explained by random effects. Toxicol. Sci. 43:1998;1-9.
35. Lu A. Y. H., Wislocki P. G., Chiu S-H. L., Miwa G. T. Tissue drug residues and their toxicological significance. Drug Metab. Rev. 18:1987;363-378.
36. MacDonald J. S., Lankas G. R., Morrissey R. E. Toxicokinetic and mechanistic considerations in the interpretation of the rodent bioassay. Toxicol. Pathol. 22:1994;124-140.
37. Matthews E. J., Machuga E. J. Threshold of estimated toxicity for regulation of indirect food additives. Toxicol. Lett. 79:1995;123-129.
38. McClain, R. M. 1994, Mechanistic considerations in the regulation and classification of chemical carcinogens, Nutritional Toxicology, F. N. KotsonisM. MackeyJ. Hjelle, 273, 304, Raven Press, New York.
39. Monro A. How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans. Adverse Drug React. Toxicol. Rev. 12:1993;5-34.
40. Monro A. Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents. Exp. Toxicol. Pathol. 48:1996;155-166.
41. Munro I. C., McGirr L. G., Nestmann E. R., Kille J. W. Alternative approaches to the safety assessment of macronutrient substitutes. Regul. Toxicol. Pharmacol. 17:1996a;S6-S14.
42. Munro I. C., Ford R. A., Kennepohl E., Sprenger J. G. Thresholds of toxicological concern based on structure-activity relationships. Drug Metab. Rev. 28:1996b;209-217.
43. Munro I. C., Ford R. A., Kennepohl E., Sprenger J. G. Correlation of structural class with no-observed-effect levels: A proposal for establishing a threshold of concern. Food Chem. Toxicol. 34:1996c;829-867.
44. National Research Council, 1996, Carcinogens and Anti-carcinogens in the Human Diet. A Comparison of Naturally Occurring and Synthetic Substances, Natl. Acad. Press, Washington, DC.
45. Parodi S., Malacarne D., Romano P., Taningher M. Are genotoxic carcinogens more potent than non-genotoxic carcinogens. Environ. Health Perspect. 95:1991;199-204.
46. Renwick A. G. Data-derived safety factors for the evaluation of food additives and environmental contaminants. Food Add. Contam. 10:1993;275-305.
47. Renwick A. G. The use of an additional safety or uncertainty factor for nature of toxicity in the estimation of acceptable daily intake and tolerable daily intake values. Regul. Pharmacol. 22:1995;250-261.
48. Rulis A. M. Making regulatory decisions across the food ingredient spectrum. Drug Metab. Rev. 28:1996;197-208.
49. Sugimura T. Past, present and future mutagens in cooked foods. Environ. Health. Perspect. 67:1986;5-10.
50. Tomatis L. Cancer: Causes, Occurrence and Control. 1990;IARC, Lyon.
51. Williams G. M. Screening procedures for evaluating the potential carcinogenicity of food-packaging chemicals. Regul. Pharmacol. Toxicol. 12:1990;30-40.
52. Williams G. M., Reiss B., Weisburger J. H. A comparison of the animal and human carcinogenicity of environmental, occupational and therapeutic chemicals. Flamm G. Advances in Modern Experimental Toxicology. 1985;207-248 Princeton Science.
53. Williams G. M., Weisburger J. H. Chemical carcinogenesis. Amdur M. O., Doull J., Klassen C. D. Casarett and Doull's Toxicology. 1991;Pergamon Press, New York.